These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25049046)

  • 21. Anakinra suppresses familial Mediterranean fever crises in a colchicine-resistant patient.
    Mitroulis I; Papadopoulos VP; Konstantinidis T; Ritis K
    Neth J Med; 2008 Dec; 66(11):489-91. PubMed ID: 19075317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Summaries for patients. Therapy for patients with familial Mediterranean fever when colchicine is not enough or is not tolerated.
    Ann Intern Med; 2012 Oct; 157(8):I-44. PubMed ID: 23070503
    [No Abstract]   [Full Text] [Related]  

  • 23. Anakinra in two adolescent female patients suffering from colchicine-resistant familial Mediterranean fever: effective but risky.
    Gattringer R; Lagler H; Gattringer KB; Knapp S; Burgmann H; Winkler S; Graninger W; Thalhammer F
    Eur J Clin Invest; 2007 Nov; 37(11):912-4. PubMed ID: 17973784
    [No Abstract]   [Full Text] [Related]  

  • 24. Response to: 'Correspondence on 'Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial'' by Satis
    Ozen S; De Benedetti F
    Ann Rheum Dis; 2022 Dec; 81(12):e257. PubMed ID: 32988842
    [No Abstract]   [Full Text] [Related]  

  • 25. Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement.
    Kallinich T; Haffner D; Niehues T; Huss K; Lainka E; Neudorf U; Schaefer C; Stojanov S; Timmann C; Keitzer R; Ozdogan H; Ozen S
    Pediatrics; 2007 Feb; 119(2):e474-83. PubMed ID: 17242135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is it possible to extend the dose interval of canakinumab treatment in children with familial Mediterranean fever? PeRA group experience.
    Kavrul Kayaalp G; Çağlayan Ş; Demirkan FG; Guliyeva V; Otar Yener G; Öztürk K; Demir F; Özdel S; Çakan M; Sönmez HE; Sözeri B; Aktay Ayaz N
    Pediatr Rheumatol Online J; 2023 Nov; 21(1):140. PubMed ID: 37996934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature.
    Meinzer U; Quartier P; Alexandra JF; Hentgen V; Retornaz F; Koné-Paut I
    Semin Arthritis Rheum; 2011 Oct; 41(2):265-71. PubMed ID: 21277619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effectiveness and safety of canakinumab in pediatric familial Mediterranean fever patients.
    Gülez N; Makay B; Sözeri B
    Mod Rheumatol; 2020 Jan; 30(1):166-171. PubMed ID: 30556769
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical improvement with infliximab in a child with amyloidosis secondary to familial Mediterranean fever.
    Yüksel S; Yalçinkaya F; Acar B; Ozçakar ZB; Oztürk B; Ekim M
    Rheumatology (Oxford); 2006 Oct; 45(10):1307-8. PubMed ID: 16880190
    [No Abstract]   [Full Text] [Related]  

  • 30. Intravenous colchicine for treatment of patients with familial Mediterranean fever unresponsive to oral colchicine.
    Lidar M; Kedem R; Langevitz P; Pras M; Livneh A
    J Rheumatol; 2003 Dec; 30(12):2620-3. PubMed ID: 14719203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colchicine is a safe drug in children with familial Mediterranean fever.
    Padeh S; Gerstein M; Berkun Y
    J Pediatr; 2012 Dec; 161(6):1142-6. PubMed ID: 22738946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of canakinumab in the treatment of a patient with familial Mediterranean fever and longstanding destructive arthritis.
    Mitroulis I; Skendros P; Oikonomou A; Tzioufas AG; Ritis K
    Ann Rheum Dis; 2011 Jul; 70(7):1347-8. PubMed ID: 21345814
    [No Abstract]   [Full Text] [Related]  

  • 33. Remission of progressive renal failure in familial Mediterranean fever during colchicine treatment.
    Herlin T; Storm K; Hamborg-Petersen B
    Arch Dis Child; 1985 May; 60(5):477-9. PubMed ID: 4015155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case report: Successful treatment with canakinumab of a patient with active ileitis associated with familial Mediterranean fever.
    Kishida D; Hara R; Ichikawa T; Iwaya M; Shimojima Y; Sekijima Y
    Int J Rheum Dis; 2024 Jan; 27(1):e15006. PubMed ID: 38069585
    [No Abstract]   [Full Text] [Related]  

  • 35. Disease severity in adult patients of Turkish ancestry with familial mediterranean fever living in Germany or Turkey. Does the country of residence affect the course of the disease?
    Giese A; Örnek A; Kilic L; Kurucay M; Şendur SN; Lainka E; Henning BF
    J Clin Rheumatol; 2013 Aug; 19(5):246-51. PubMed ID: 23872541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy of interferon alpha on colchicine-resistant familial Mediterranean fever attacks: a pilot study.
    Tunca M; Tankurt E; Akbaylar Akpinar H; Akar S; Hizli N; Gönen O
    Br J Rheumatol; 1997 Sep; 36(9):1005-8. PubMed ID: 9376975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between ABCB1 (MDR1) gene 3435 C>T polymorphism and colchicine unresponsiveness of FMF patients.
    Ozen F; Silan C; Uludag A; Candan F; Silan F; Ozdemir S; Atik S; Ozdemir O
    Ren Fail; 2011; 33(9):899-903. PubMed ID: 21851199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of canakinumab treatment on growth parameters in children with familial Mediterranean fever.
    Aydin EA; Baglan E; Kocamaz NG; Bagrul İ; Tuncez S; Ozdel S
    Clin Rheumatol; 2024 Jan; 43(1):387-392. PubMed ID: 37658934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-alpha as a treatment modality for colchicine- resistant familial Mediterranean fever.
    Tweezer-Zaks N; Rabinovich E; Lidar M; Livneh A
    J Rheumatol; 2008 Jul; 35(7):1362-5. PubMed ID: 18528960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of familial Mediterranean fever with colchicine].
    Alarcón Zurita A; Dalmau M; Morey A; Marco J; Bestard J; Pizá C; Mairata S
    Rev Clin Esp; 1981 Dec; 163(5):311-2. PubMed ID: 7342187
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.